Corrigendum.
- Published in:
- 2023
- Publication type:
- Correction Notice
Works matching IS 10600280 AND DT 2023 AND VI 57 AND IP 9
Results: 16
1
2
Comparison of Sedation and Analgesia Requirements in Patients With SARS-CoV-2 Versus Non-SARS-CoV-2 Acute Respiratory Distress Syndrome on Veno-Venous ECMO.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1005, doi. 10.1177/10600280221147695
- By:
- Publication type:
- Article
3
Tretinoin 0.1% and Benzoyl Peroxide 3% Cream for the Treatment of Facial Acne Vulgaris.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1088, doi. 10.1177/10600280221147338
- By:
- Publication type:
- Article
4
Applying Design-Thinking Principles to Practice-Based Pharmacy Research.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1111, doi. 10.1177/10600280221147014
- By:
- Publication type:
- Article
5
Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1016, doi. 10.1177/10600280221146878
- By:
- Publication type:
- Article
6
Comparison of Methicillin-Resistant Staphylococcus aureus Nasal Screening Predictive Value in the Intensive Care Unit and General Ward.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1036, doi. 10.1177/10600280221145152
- By:
- Publication type:
- Article
7
Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1118, doi. 10.1177/10600280221144936
- By:
- Publication type:
- Article
8
Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1117, doi. 10.1177/10600280221144932
- By:
- Publication type:
- Article
9
Psychedelics for Patients With Cancer: A Comprehensive Literature Review.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1062, doi. 10.1177/10600280221144055
- By:
- Publication type:
- Article
10
Tecovirimat Use in Combination With Fixed-Dose Bictegravir in a Person With HIV and Concurrent Monkeypox.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1122, doi. 10.1177/10600280221144025
- By:
- Publication type:
- Article
11
Daridorexant: Comprehensive Review of A New Oral Agent for the Treatment of Insomnia.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1076, doi. 10.1177/10600280221143794
- By:
- Publication type:
- Article
12
The Effect of the Drug-Related Problems Prevention Bundle on Early Readmissions in Patients From the Emergency Department: A Randomized Clinical Trial.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1025, doi. 10.1177/10600280221143237
- By:
- Publication type:
- Article
13
Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1044, doi. 10.1177/10600280221141918
- By:
- Publication type:
- Article
14
Comment: Analysis of Bicarbonate-Based Purge Solution in Patients With Cardiogenic Shock Supported Via Impella Ventricular Device.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1120, doi. 10.1177/10600280221139458
- By:
- Publication type:
- Article
15
A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1053, doi. 10.1177/10600280221139245
- By:
- Publication type:
- Article
16
Review of Dual Biologics in Specialty Pharmacy Practice.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 9, p. 1094, doi. 10.1177/10600280221135177
- By:
- Publication type:
- Article